Prior to starting Ocular Therapeutix, Amar Sawhney, already a successful medtech entrepreneur was a bit concerned about the unique challenges posed by the ophthal-mology sector. Today, with the commercial launch of its ReSure Sealant underway and a suc-cessful IPO completed, Sawhney says he’s more than confident in the plan to build OCUL into a significant ophthalmic player.